AI in life sciences raises various patent law considerations, including subject matter eligibility, novelty/obviousness, and ...

A looming patent cliff is driving Big Pharma reorganization. Executives making career moves must understand differences in ...

The treatment landscape for autoimmune and inflammatory diseases has evolved through three distinct phases. The first era, dating back as far as the 1960s, relied on broad immunosuppressants such as ...